Log in to your Inderes Free account to see all free content on this page.
Spermosens
0.01 SEK
0.00 %
Less than 1K followers
SPERM
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Spermosens
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | |||||
| growth-% | 442.9 % | ||||||
| EBITDA | - | -2.0 | -6.2 | -12.5 | -10.9 | -9.2 | -9.0 |
| EBIT | - | -2.0 | -6.2 | -12.5 | -10.9 | -9.2 | -9.2 |
| Profit before taxes | -2.0 | -6.4 | -12.7 | -12.2 | -10.2 | -9.2 | |
| Net income | - | -2.0 | -6.4 | -12.7 | -12.2 | -10.2 | -9.2 |
| EPS | 0.00 | -0.02 | -0.08 | -0.14 | -0.07 | -0.04 | -0.00 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -29,171.4 % | -16,189.5 % | |||||
| EBIT-% | -29,171.4 % | -16,189.5 % | |||||
| ROE | -59.8 % | -27.2 % | -42.8 % | -96.1 % | -37.3 % | -28.4 % | |
| ROI | -20.6 % | -25.0 % | -37.9 % | -46.7 % | -32.9 % | -27.1 % |
Login required
This content is only available for logged in users